KFS
Kaizen Financial Strategies’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-607
| Closed | -$302K | – | 155 |
|
|
2025
Q1 | $302K | Buy |
607
+4
| +0.7% | +$1.99K | 0.17% | 102 |
|
|
2024
Q4 | $314K | Sell |
603
-205
| -25% | -$107K | 0.18% | 98 |
|
|
2024
Q3 | $500K | Buy |
808
+2
| +0.2% | +$1.24K | 0.29% | 57 |
|
|
2024
Q2 | $496K | Sell |
806
-64
| -7% | -$39.4K | 0.31% | 52 |
|
|
2024
Q1 | $506K | Hold |
870
| – | – | 0.34% | 53 |
|
|
2023
Q4 | $462K | Sell |
870
-199
| -19% | -$106K | 0.35% | 53 |
|
|
2023
Q3 | $541K | Hold |
1,069
| – | – | 0.46% | 38 |
|
|
2023
Q2 | $562K | Buy |
1,069
+3
| +0.3% | +$1.58K | 0.48% | 38 |
|
|
2023
Q1 | $615K | Sell |
1,066
-202
| -16% | -$116K | 0.61% | 36 |
|
|
2022
Q4 | $740K | Buy |
1,268
+250
| +25% | +$146K | 0.73% | 37 |
|
|
2022
Q3 | $516K | Buy |
1,018
+200
| +24% | +$101K | 0.52% | 48 |
|
|
2022
Q2 | $444K | Buy |
818
+128
| +19% | +$69.5K | 0.44% | 60 |
|
|
2022
Q1 | $407K | Buy |
690
+39
| +6% | +$23K | 0.32% | 73 |
|
|
2021
Q4 | $435K | Hold |
651
| – | – | 0.33% | 82 |
|
|
2021
Q3 | $372K | Buy |
+651
| New | +$372K | 0.3% | 86 |
|
|
2021
Q1 | $297K | Buy |
651
+1
| +0.2% | +$456 | 0.28% | 105 |
|
|
2020
Q4 | $303K | Buy |
+650
| New | +$303K | 0.34% | 90 |
|